Počet záznamov: 1
skúšanie klinické, fáza II, ako téma
SYS d017322 LBL 00000cx--j2200000---45-- 005 20240119200157.0 100 $a 19920513asloy0103----ba0 152 $b mesh 250 $a skúšanie klinické, fáza II, ako téma $x CL $x EC $x ES $x HI $x IS $x LJ $x MT $x PX $x SN $x ST $x VE $8 slo 300 1-
$a 2008(1993) $8 eng 300 1-
$a Clinical Trials (1980-1992) $8 eng 300 1-
$a Drug Evaluation (1980-1992) $8 eng 330 1-
$a Works about studies that are usually controlled to assess the effectiveness and dosage (if appropriate) of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques. These studies are performed on several hundred volunteers, including a limited number of patients with the target disease or disorder, and last about two years. This concept includes phase II studies conducted in both the U.S. and in other countries. $8 eng 450 $a pokusy klinické, druhá fáza, ako téma $5 e $8 slo 450 $a testy klinické, druhá fáza, ako téma $5 e $8 slo 450 $a štúdie klinické, fáza II, ako téma $5 e $8 slo 675 $a 615.036 686 $a E05.318.372.250.250.210 686 $a N05.715.360.330.250.250.210 686 $a N06.850.520.450.250.250.210 750 $a Clinical Trials, Phase II as Topic $8 eng 801 -0
$a US $b DNLM $c 19920513 801 -2
$a SK $b BA006 $c 19990922 801 -2
$a SK $b BA006 $c 20080702 801 -2
$a SK $b BA006 $c 20160216 820 $a for general design, methodology, economics, etc. of phase II clinical trials; a different heading CLINICAL TRIAL, PHASE II is used for reports of a specific phase II clinical trial $8 eng 980 $x M
Počet záznamov: 1